ALPINE IMMUNE SCIENCES

alpine-immune-sciences-logo

Alpine Immune Sciences is a clinical-stage biopharmaceutical business focused on researching and developing protein-based immunotherapies to treat autoimmune and inflammatory disorders. Its strategy incorporates a patented scientific platform for transforming native immune system proteins into differentiated, multi-targeted therapies. ALPN-303, or povetacicept, is a dual antagonist of the B cell activating factor, or BAFF, and a proliferation-inducing ligand, or APRIL, cytokines, which play key roles in the activation, development, and survival of B cells, and ALPN-101, or acazicolcept, is a dual Inducible T cell Costimulator, or ICOS, and CD28 antagonist intended for the treatment of autoimmune and inflammatory diseases.
#SimilarOrganizations #People #Financial #Event #Website #More

ALPINE IMMUNE SCIENCES

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical

Founded:
2015-01-23

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.alpineimmunesciences.com

Total Employee:
101+

Status:
Active

Contact:
(206)441-5062

Total Funding:
475.3 M USD

Technology used in webpage:
Content Delivery Network IPv6 ReCAPTCHA ReCAPTCHA V2 CloudFront Gravity Forms ASP.NET Ajax Google Analytics IP Anonymization CenturyLink Q4Web


Similar Organizations

coriell-life-sciences-logo

Coriell Life Sciences

Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.

dermavant-sciences-logo

Dermavant Sciences

Dermavant Sciences is a biotechnology company focused on dermatology.

eikon-therapeutics-logo

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

not_available_image

Georgiamune

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

gritstone-bio-logo

Gritstone Bio

Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.

ocean-biomedical-logo

Ocean Biomedical

Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.


Current Advisors List

marc-gavin_image

Marc gavin Scientific Advisor @ Alpine Immune Sciences
Advisor

jay-venkatesan_image

Jay Venkatesan President & Director @ Alpine Immune Sciences
Board_member

andrew-scharenberg_image

Andrew Scharenberg Scientific Advisor @ Alpine Immune Sciences
Advisor
2016-04-01

peter-thompson_image

Peter Thompson Board of Directors @ Alpine Immune Sciences
Board_member
2016-06-01

Current Employees Featured

amanda-enstrom_image

Amanda Enstrom
Amanda Enstrom Senior Director Clinical Biomarkers (Translational Medicine) @ Alpine Immune Sciences
Senior Director Clinical Biomarkers (Translational Medicine)
2022-04-01

mitchell-gold_image

Mitchell Gold
Mitchell Gold Co-founder and Executive Chairman @ Alpine Immune Sciences
Co-founder and Executive Chairman
2015-01-01

mitchell-h-gold_image

Mitchell H. Gold
Mitchell H. Gold Co-founder Executive Chairman & CEO @ Alpine Immune Sciences
Co-founder Executive Chairman & CEO
2015-01-01

wolfgang-dummer_image

Wolfgang Dummer
Wolfgang Dummer Chief Medical Officer @ Alpine Immune Sciences
Chief Medical Officer
2023-10-01

kristi-manjarrez_image

Kristi Manjarrez
Kristi Manjarrez Vice President, Clinical Affairs @ Alpine Immune Sciences
Vice President, Clinical Affairs
2018-07-01

remy-durand_image

Remy Durand
Remy Durand Chief Business Officer @ Alpine Immune Sciences
Chief Business Officer
2021-01-01

Founder


michael-kornacker_image

Michael Kornacker

mitchell-gold_image

Mitchell Gold

mitchell-h-gold_image

Mitchell H. Gold

ryan-swanson_image

Ryan Swanson

Stock Details


Company's stock symbol is NASDAQ:ALPN

Acquisitions List

Date Company Article Price
2017-07-20 Nivalis Therapeutics Nivalis Therapeutics acquired by Alpine Immune Sciences N/A

Investors List

tcg-crossover_image

TCG Crossover

TCG Crossover investment in Post-IPO Equity - Alpine Immune Sciences

omega-funds_image

Omega Funds

Omega Funds investment in Post-IPO Equity - Alpine Immune Sciences

decheng-capital_image

Decheng Capital

Decheng Capital investment in Post-IPO Equity - Alpine Immune Sciences

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - Alpine Immune Sciences

avidity-partners_image

Avidity Partners

Avidity Partners investment in Post-IPO Equity - Alpine Immune Sciences

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Alpine Immune Sciences

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Post-IPO Equity - Alpine Immune Sciences

logos-capital_image

Logos Capital

Logos Capital investment in Post-IPO Equity - Alpine Immune Sciences

avidity-partners_image

Avidity Partners

Avidity Partners investment in Post-IPO Equity - Alpine Immune Sciences

omega-funds_image

Omega Funds

Omega Funds investment in Post-IPO Equity - Alpine Immune Sciences

Official Site Inspections

http://www.alpineimmunesciences.com Semrush global rank: 2.94 M Semrush visits lastest month: 5.39 K

  • Host name: crs.ultradns.net
  • IP address: 204.74.99.100
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Alpineimmunesciences.com lookup results from whois.corporatedomains.com server:
  • Domain created: 28th-Oct-2014
  • Domain updated: 11th-Oct-2024
  • Domain expires: 28th-Oct-2026 1 Year, 125 Days left
  • Website age: 10 Years, 239 Days
  • Registrar Domain ID: 1882649139_DOMAIN_COM-VRSN
  • Registrar Url: http://cscdbs.com
  • Registrar WHOIS Server: whois.corporatedomains.com
  • Registrar Abuse Contact Email: domainabuse@cscglobal.com
  • Registrar Abuse Contact Phone: 8887802723
  • Name server:
    • UDNS1.CSCDNS.NET
    • UDNS2.CSCDNS.UK

More informations about "Alpine Immune Sciences"

Alpine Immune Sciences - Crunchbase Company …

Alpine Immune Sciences is a clinical-stage biopharmaceutical business focused on researching and developing protein-based immunotherapies to treat …See details»

Alpine Immune Sciences, Inc. | LinkedIn

Alpine Immune Sciences is now part of Vertex Pharmaceuticals. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with ...See details»

Alpine Immune Sciences, Inc. Company Overview, Contact Details ...

Nov 6, 2023 John.Doe@alpineimmunesciences.com: 46%. FLast@alpineimmunesciences.com: JDoe@alpineimmunesciences.com: 4%. See more formats. Frequently Asked Questions …See details»

Alpine Immune Sciences, Inc. - Company Profile & Staff

Alpine Immune Sciences is a clinical stage biopharmaceutical company dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to …See details»

Alpine Immune Sciences, Inc. Overview - SignalHire

Organization Website. alpineimmunesciences.com . Social Links. Phone Number. 206-788-4545. Alpine Immune Scienc... industries. Biotech, Biotechnology Headquarters Location. 188 E …See details»

Alpine Immune Sciences, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Alpine Immune Sciences, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»

Alpine Immune Sciences - PitchBook

May 7, 2021 Alpine Immune Sciences General Information Description. Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company dedicated to discovering and developing protein-based immunotherapies to treat …See details»

Alpine Immune Sciences - Company Profile - Tracxn

Jan 4, 2025 Alpine Immune Sciences - Developer of immunotherapies to treat cancer and autoimmune disorders. Acquired by Vertex Pharmaceuticals. Raised a total funding of $49.2M …See details»

Alpine Immune Sciences - Overview, News & Similar companies

May 9, 2024 Who is Alpine Immune Sciences. Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, …See details»

Company Alpine Immune Sciences, Inc. Deutsche Boerse AG

May 19, 2024 Alpine Immune Sciences, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche …See details»

Alpine Immune Sciences - VentureRadar

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a... ... Find out more ...See details»

Alpine Immune Sciences - Products, Competitors, Financials, …

Headquarters Location. 188 East Blaine Street Suite 200. Seattle, Washington, 98102, United States. 206-788-4545See details»

Alpine Immune Sciences - News, Mergers and Acquisitions, …

Usearch identified 3 signals for Alpine Immune Sciences, including: 3 Mergers and Acquisitions. Usearch discovered 1 location for Alpine Immune Sciences including locations in Seattle · …See details»

Alpine Immune Sciences - Craft

Alpine Immune Sciences has 3 employees across 2 locations, $49.3 m in total funding, and $58.88 m in annual revenue in FY 2023. See insights on Alpine Immune Sciences including …See details»

Alpine Immune Sciences - workinbiotech.com

Alpine Immune Sciences is taking a unique approach to immunology to treat cancer, autoimmune and inflammatory diseases. Alpine is using protein engineering strategies, such as their …See details»

Alpine Immune Sciences, Inc.: Culture | LinkedIn

Alpine Immune Sciences, Inc. Biotechnology Research Seattle, Washington 9,670 followers Leading the Next Evolution of ImmunotherapiesSee details»

Alpine Immune Sciences Announces Company Presentation and …

Apr 5, 2022 Investor Relations Alex Sharif Director, Investor Relations and Corporate Development Alpine Immune Sciences, Inc 206-788-4545 ir@alpineimmunesciences.com …See details»

Working at Alpine Immune Sciences - Zippia

Www.alpineimmunesciences.com. Organization Type. Public. CEO. Mitchell H. Gold M.d. Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein …See details»

Alpine Immune Sciences Provides Corporate Update and Reports …

Mar 17, 2022 Alex Sharif Director, Investor Relations and Corporate Development Alpine Immune Sciences, Inc. 206-788-4545 ir@alpineimmunesciences.com Kelli Perkins (Media) …See details»

Alpine Immune - Alpine Immune Sciences to Participate in …

Feb. 22, 2021- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and …See details»

linkstock.net © 2022. All rights reserved